OUR PRODUCTS & SERVICES
We offer world-class advanced thinking that combines the latest healthcare technologies, telemedicine, and prediction to give your entire family comprehensive healthcare facilities.
AI based Screening
Diabetic Retinopathy, Age-related Macular Degeneration (AMD), and Glaucoma
Technology is advancing at an incredible rate. iHealthScreen has harnessed this momentum and contributed to healthcare with artificial intelligence that can predict and therefore help prevent blindness.
Electronic Health Record (EHR) Solutions
Book appointments & consult with a physician online
You can get started with just four simple steps:
1. Book an appointment. 2. Input your health information. 3. Enter your chosen payment method online. 4. Get connected & consult your doctor online.
Online Health Risk Prediction System
iHealthScreen has developed an online risk prediction system for diabetic, stroke, and heart attack patients. We have achieved a hassle-free way to deliver simple results and suggestions to the patient and doctor.
The Retinal Vessel, Retinal Pathology and Optical Coherence Tomography (OCT) Inspector.
An Optical Coherence Tomography (OCT) inspector is used to find and monitor retinal diseases through an automated method of segmentation of the retinal layer in two and three dimensions.
Facilitating the health sector with Artificial intelligence and modern technology to save lives, time and money.
iHealthScreen Inc. is a startup that has already won an impressive research fund of 2.5 MILLION DOLLARS from USA National Institute of Health (NIH), and is in the process of receiving $6.5 MILLION from private investors and NIH research grants. The company already has international influence with contracts in the US and Bangladesh. The contracts in the US are with top hospitals such as Mount Sinai and other various clinics. In Bangladesh, the company has partnered with the Bangladesh Diabetes Society to screen 5 MILLION diabetic patients who are at risk of developing Diabetic Retinopathy.See More
A Prediction Model for Risk of Progression to Late Age-related Macular Degeneration (AMD)
Dr. Alauddin BhuiyanDecember 06, 2018
iHealthScreen aims to develop novel innovative software for retinal image grading and diagnosis of diseases, and screen disease - to predict or detect at early stage.
Our Partners and Collaborators
iHealthScreen Inc. annonce la certification CE du système IA automatisé iPredict™ pour le dépistage précoce de la rétinopathie (RD), la dégénérescence maculaire liée à l’âge (DMLA) et les cas suspects de glaucome
NEW YORK–(BUSINESS WIRE)–iPredict™ un système d’intelligence artificielle (IA) d’analyse de l’œil permet le dépistage entièrement automatique de la rétinopathie (RD)
iPredict™ Automated AI Eye Screening System for Early Diagnosis of Diabetic Retinopathy (DR), Age Related Macular Degeneration (AMD), and Glaucoma Suspect iHealthScreen Inc. Announces CE Certification for this.
iPredict™ AI Eye Screening System provides fully automated diabetic retinopathy (DR), age related macular degeneration (AMD), and glaucoma suspect screening, including retinal imaging, and immediate reporting of actionable results…
iHealthScreen Inc. Announces CE Certification for iPredictTM Automated AI Eye Screening System for Early Diagnosis of Diabetic Retinopathy (DR), Age Related Macular degeneration (AMD), and Glaucoma Suspect
NEW YORK–(BUSINESS WIRE)– iPredictTM AI Eye Screening System provides fully automated diabetic retinopathy (DR), age related macular degeneration (AMD), and glaucoma suspect screening, including retinal imaging, and immediate reporting of actionable results …